Jens Bjørheim
Chief Tech/Sci/R&D Officer at ULTIMOVACS ASA
Net worth: - $ as of 2024-04-29
Jens Bjørheim active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ULTIMOVACS ASA | Chief Tech/Sci/R&D Officer | - | - |
Career history of Jens Bjørheim
Former positions of Jens Bjørheim
| Companies | Position | Start | End |
|---|---|---|---|
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | 2012-12-31 | 2015-12-31 |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Chief Tech/Sci/R&D Officer | 2005-12-31 | 2007-12-31 |
Training of Jens Bjørheim
| University of Oslo | Doctorate Degree |
Statistics
International
| Norway | 4 |
| Denmark | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ULTIMOVACS ASA | Health Technology |
| Private companies | 2 |
|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway. | Health Technology |
- Stock Market
- Insiders
- Jens Bjørheim
- Experience
